Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
| ERICKSON AIR | EAC | 5.10% |
| ASSURED GUAR | AGO | 4.98% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Ventas, Inc. (VTR - Analyst Report) a leading health care real estate investment trust (REIT), has recently accomplished a deal by which the company along with the management team of Atria Senior Living, Inc. gained complete ownership over Atria.
Ventas executed the deal through the acquisition of 100% of several private investment funds formerly managed by Lazard Frères Real Estate Investors LLC (‘LFREI’) or its affiliates. Funds acquired now possess a 34% interest in Atria and 3.7 million shares of Ventas common stock. The amount required for this purchase of interests was around $242 million. Notably, executives and employees of Atria have a 66% stake in Atria.
Atria will carry on managing a portfolio of 118 private pay senior living communities comprising around 13,600 units for Ventas, which are situated in major metropolitan markets.
The Back Story
In May 2011, Ventas substantially acquired all of the real estate assets and working capital of privately-owned Atria Senior Living Group Inc. (ASLG). However, at that time, private equity funds managed by LFREI or its affiliates owned ASLG.
Before the closing of the deal, ASLG spun off its management operations to a newly formed entity named Atria Senior Living Inc., which continued to be substantially owned and controlled by LFREI or its affiliates. Post-acquisition, Atria continues to manage these properties.
In Conclusion
Ventas, primarily engaged in the business of financing, owning and leasing healthcare related and senior housing facilities, boasts one of the largest and most diversified portfolios in the healthcare sector with exposure to all types of facilities.
The product diversity of the company allows it to capitalize on opportunities in different markets based on individual market dynamics, and provides a hard-to-replicate competitive advantage over its peers. This recent transaction further creates additional growth prospects.
Ventas received specific rights and minority protections concerning material transactions impacting Atria and is permitted two seats on Atria’s board. Further, Ventas put an end to its commitment related to the “Earnout,” a contingent performance-based payment that resulted from Ventas’s 2011 acquisition of 117 Atria-managed senior living communities, for an additional $44 million. However, this transaction is likely to be minimally accretive to Ventas’s 2013 normalized funds from operations (FFO) per share.
Ventas currently retains a Zacks #2 Rank, which translates into a short-term Buy rating. One of its competitors, HCP, Inc (HCP - Analyst Report) currently retains a Zacks #3 Rank, which translates into a short-term Hold rating.
Get the full Analyst Report on HCP - FREE
Get the full Analyst Report on VTR - FREE